RENEE KEENAN: Open Payments
NPI 1407215569 · ABINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,619 in 70 payments from 17 companies in 2025. Trend: 2023 $699 · 2024 $1,707 · 2025 $2,619
Food & beverage: $2,619
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 12 | $803 |
| AstraZeneca Pharmaceuticals LP | 8 | $281 |
| BridgeBio Pharma, Inc. | 4 | $270 |
| Alnylam Pharmaceuticals Inc. | 7 | $256 |
| E.R. Squibb & Sons, L.L.C. | 7 | $186 |
| CVRx, Inc. | 2 | $169 |
| AtriCure, Inc. | 4 | $156 |
| Novartis Pharmaceuticals Corporation | 6 | $106 |
| PFIZER INC. | 5 | $106 |
| Merck Sharp & Dohme LLC | 5 | $100 |
Products named: THORATEC HEARTMATE 3 LVAS IMPLANT KIT, Attruby, WAINUA, CAMZYOS, Barostim Neo System, AMVUTTRA, ONPATTRO, LEQVIO.
Industry payments across PA — which companies pay providers there.
